期刊文献+

Dapper在多发性骨髓瘤发病机制中的作用 被引量:3

Role of Dapper in the Pathogenesis of Multiple Myeloma
下载PDF
导出
摘要 Wnt信号通路参与细胞的分化、增殖和凋亡,并在多种肿瘤的发生、发展中起着重要作用。Dapper是一类新发现的信号调控分子家族,是散乱蛋白Dishevelled的相互作用蛋白,而散乱蛋白是Wnt信号通路中关键性的正向调控因子。多发性骨髓瘤(MM)的发病机制复杂,在分子生物学上需要许多信号通路参与。该文就Dapper的生物学特性及其在MM发生、发展中的作用研究进行阐述。 Wnt signaling pathway takes part in cells' differentiation, proliferation and apoptosis, and plays an important role in many tumors' genesis and development. Dapper is a newly discovered family of sig- nal regulatory molecule, as Dishevelled-interacting regulators of Wnt signaling pathway, while Dishevelled is an important positive regulator of Wnt signal pathway. The mehanism of multiple myeloma is complicated, which includes lots of signal pathways. Here is to make a review on the biological characteristics of Dapper, and its roles in the formation and develonment of multinle mveloma.
作者 何青 汪兴洪
出处 《医学综述》 2013年第9期1589-1591,共3页 Medical Recapitulate
关键词 Dapper 多发性骨髓瘤 WNT信号通路 Dapper Multiple myeloma Wnt signaling pathway
  • 相关文献

参考文献18

  • 1Cheyette BN,Waxman JS, Miller JR,ei al. Dapper,a Dishevelled-associated antagonist of (3-catenin and JNK signaling, is requiredfor notochord formation[ J]. Dev Cell,2002,2(4) :449-461.
  • 2Gloy J, Hikasa H, Sokol SY. Frodo interacts with Dishevelled totransduce Wnt signals[ J]. Nat Cell Biol,2002,4(5) :351-357.
  • 3Katoh M, Katoh M. Identification and characterization of humanDAPPER1 and DAPPER2 genes in silico [ J] . Int J Oncol, 2003 ,22(4) :907-913.
  • 4Yau TO,Chan CY,Chan KL,et al. HDPR1, a novel inhibitor of theWNT/beta-catenin signaling, is frequently downregulated in hepa-tocellular carcinoma: involvement of methylation-mediated genesilencing[ J]. Oncogene,2005 ,24(9) : 1607-1614.
  • 5高霞,陈旭煌,陈晔光.Dapper在胚胎发育和信号调控中的作用[J].生命科学,2007,19(5):471-476. 被引量:3
  • 6Luo W,Zou H, Jin L,ei al. Axin contains three separable domainsthat confer intramolecular, homodimeric, and heterodimeric interac-tions involved in distinct functions [ J]. J Biol Chem,2005 , 280(6):5054-5060.
  • 7Krieghoff E,Behrens J, Mayr B. Nucleo-cytoplasmic distribution ofbeta-catenin is regulated by retention [ J]. J Cell Sci, 2006 , 119(Pt 7) :1453-1463.
  • 8Ge X. Wang X. Role of Wnt canonical pathway in hematologicalMalignancies[ J]. J Hematol Oncol ,2010,3 :33.
  • 9Logan CY, Nusse R. The Wnt signaling pathway in developmentand disease [ J]. Annu Rev Cell Dev Biol, 2004, 20 : 781 -810.
  • 10Lilien J, Balsamo J. The regulation of cadherin-mediatedadhesion by tyrosine phosphorylation/dephosphorylation of beta-catenin [J]. Curr Opin Cell Biol,2005 ,17(5) :459465.

二级参考文献33

  • 1YeGuangCHEN,AnMingMENG.Negative regulation of TGF-β signaling in development[J].Cell Research,2004,14(6):441-449. 被引量:3
  • 2Zavrski I, Krebbel H, Wildemann B, et al. Proteasome inhibitors abrogate osteoclast differentiation and osteoclast function. Biochem Biophys Res Commun, 2005 ;333:200 - 205
  • 3Zavrski J, Jakob C, Schmid P, et al. Proteosome: an emerging target for cancer therapy. Anti-Cancer Drug, 2005; 23:475 -481
  • 4Giuliani N, Rizzoli V, Roodman GD. Multiple myeloma bone disease: pathophysiology of osteoblast inhibition. Blood,2006; 108: 3992 - 3996
  • 5Abe M, Hiura K, Wilde J, et al. Osteoclasts enhance myeloma cell growth and survival via cell-cell contact: a vicious cycle between bone destruction and myeloma expansion. Blood,2004; 104:2484 - 2491
  • 6Matsumoto T, Abe M. Bone destruction in multiple myeloma. Ann N Y Acad Sci ,2006 ; 1068:319 - 326
  • 7Yeh HS, Berenson JR. Myeloma bone disease and treatment options. Eur J Cancer, 2006 ;42 : 1554 - 1563
  • 8Silvestris F, Lombardi L, De Matteo M, et al. Myeloma bone disease: Pathogenetic mechanisms and clinical assessment. Leuk Res, 2007; 31:129 -138
  • 9Choi SJ, Cruz JC, Craig F, et al. Macrophage inflammatory protein 1-alpha is a potential osteoclast stimulatory factor in multiple myeloma. Blood ,2000 ;96:671 - 675
  • 10Gunn WG, Conley A, Deininger L,et al. A cmsstalk between myeloma cells and marrow stmmal cells stimulates production of DKK1 and interleukin-6: a potential role in the development of lyric bone disease and tumor progression in multiple myeloma. Stem Cells, 2006;24:986 -991

共引文献6

同被引文献22

引证文献3

二级引证文献3

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部